Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting Program | Zendy

Yves Longtin | Zendy; Sylvie Trottier | Zendy; Gilles Brochu | Zendy; Bianka Paquet-Bolduc | Zendy; Christophe Garenc | Zendy; Vilayvong Loungnarath | Zendy; Catherine Beaulieu | Zendy; Danielle Goulet | Zendy; Jean Longtin | Zendy

Open Access

Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting Program

Author(s) -

Yves Longtin,

Sylvie Trottier,

Gilles Brochu,

Bianka Paquet-Bolduc,

Christophe Garenc,

Vilayvong Loungnarath,

Catherine Beaulieu,

Danielle Goulet,

Jean Longtin

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis840

Subject(s) - medicine , clostridium difficile , incidence (geometry) , confidence interval , gastroenterology , complication , rate ratio , univariate analysis , poisson regression , surgery , antibiotics , microbiology and biotechnology , multivariate analysis , biology , population , physics , optics , environmental health

Most Clostridium difficile infection (CDI) surveillance programs neither specify the diagnostic method to be used nor stratify rates accordingly. We assessed the difference in healthcare-associated CDI (HA-CDI) incidence and complication rates obtained by 2 validated diagnostic methods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research